ETON PHARMACEUTICALS INC. - COMMON STOCK
17,34
02-мая-25 16:45:00
15 мин. задержка
Акции
+0,37
+2,18%
Сегодняшний диапазон
16,85 - 17,49
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
03 май 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
16 мар 2023 16:01:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600
15 мар 2023 06:50:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023
07 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection
11 янв 2023 06:50:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results
10 ноя 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
02 ноя 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference
18 окт 2022 06:50:00 Источник Nasdaq GlobeNewswire
-
13 сен 2022 09:00:01 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
30 авг 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Second Quarter 2022 Financial Results
11 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022
02 авг 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ (Zonisamide Oral Suspension)
18 июл 2022 07:05:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Sale of Hospital Products
24 июн 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports First Quarter 2022 Financial Results
12 май 2022 16:02:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
03 май 2022 16:02:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Appoints James Gruber as Chief Financial Officer
11 апр 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces FDA Approval of Cysteine Hydrochloride Injection
11 апр 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Fourth Quarter 2021 Financial Results
16 мар 2022 16:02:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Fourth Quarter 2021 Financial Results on Wednesday, March 16, 2022
08 мар 2022 08:00:01 Источник Nasdaq GlobeNewswire